Asian American Medical Group (ASX:AJJ) - Executive Chairman, Dr Tan Kai Chah
Executive Chairman, Dr Tan Kai Chah
Source: Now! Singapore
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Asian American Medical Group (AJJ) has partnered with London’s King’s College Hospital to set up a liver centre in Hainan, China
  • Significantly, this marks the first standalone liver centre in the Boao Lecheng International Medical Tourism Pilot Zone
  • The centre offers industry-leading facilities that will support patients in the region suffering from viral infections that lead to liver cirrhosis and cancer
  • Additionally, the centre will be directed by company Chairman Dr Tan Kai Chah, who spent the late 80s and early 90s pioneering many liver transplants
  • Partnering with the King’s College Hospital will allow the company to provide affordable and quality treatment for local and visiting patients
  • Company shares ended the day trading flat at 5.5 cents

Asian American Medical Group (AJJ) has partnered with London’s King’s College Hospital to set up a liver centre in Hainan, China.

Significantly, this centre marks the first standalone liver centre in the Boao Lecheng International Medical Tourism Pilot Zone.

The King’s College Hospital Liver Centre will support patients from China and the Association of Southeast Asian Nations (ASEAN) region. When combined, these areas have the world’s largest concentration of patients suffering from hepatitis viral infections that lead to liver cirrhosis and cancer.

“Fatty liver disease is a new scourge in this part of the world. This partnership with an eminent and highly respected centre like King’s College Hospital, will position us well to provide affordable and quality treatment for both local and visiting patients,” AAMG Executive Chairman Dr Tan Kai Chah said.

The new liver centre offers industry-leading facilities and a vast range of services. Additionally, the centre is located on a tropical island with resort facilities that attract millions of tourists — making it an inviting place for those who need to rest and recuperate after their medical treatments.

Dr Tan will direct the liver centre as he trained in both paediatric and hepatobiliary surgery and liver transplant surgery at King’s College Hospital between 1986 and 1994.

While at King’s, Dr Tan conducted the first paediatric living donor liver transplant in the U.K. He also led the living donor liver transplantation programs at the National University Hospital in Singapore and the Gleneagles Hospital.

The King’s College Hospital Liver Centre had a soft launch in November last year and is set to benefit from the incentives and tax breaks that apply within the Pilot Zone and Hainan as a free port.

Company shares ended the day trading flat at 5.5 cents.

AJJ by the numbers
More From The Market Herald
Bod Australia (ASX:BOD) - CEO, Jo Patterson

" Bod Australia (ASX:BOD) completes successful study on new medicinal cannabis product

Bod Australia (ASX:BOD) sees positive results from its study into the safety and efficacy of a…

" Wellfully (ASX:WFL) launches Swisswell Boost, trims Board

Wellfully (ASWX:WFL) has launched its upcoming innovation, the Swisswell Boost.
The Market Herald Video

" Althea (ASX:AGH) enters Irish medicinal cannabis market

Althea (ASX:AGH) has received approval from the Health Products Regulatory Authority (HPRA) for its CBD12:THC10 product…
The Market Herald Video

" Emryia’s (ASX:EMD) EMD-RX5 CBD capsule shows “excellent” outcomes

Emyria (ASX:EMD) has reported positive data from its phase one trial for its EMD-RX5 "ultra-pure" CBD…